Among populations at high risk of HIV, there is a high acceptance of pre-exposure prophylaxis (PrEP) – antiretroviral (ARV) drugs used by HIV-negative people to reduce the risk of their acquiring HIV – a new Kenyan study has found. The. In accordance with Resolution ITU-R 2-7, the CPM shall prepare a consolidated Report on the ITU-R preparatory studies and possible solutions to the WRC agenda items, [Bill Ackerman for Shaw…